These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18369381)

  • 1. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
    Guan M; Tripathi V; Zhou X; Popescu NC
    Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.
    Zhou X; Yang XY; Popescu NC
    Biochem Biophys Res Commun; 2012 Apr; 420(2):325-30. PubMed ID: 22425986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
    Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
    Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
    Tripathi V; Popescu NC; Zimonjic DB
    Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
    Zhao Y; Li Z; Sheng W; Miao J; Yang J
    Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
    Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
    Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
    Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
    Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLC1 negatively regulates angiogenesis in a paracrine fashion.
    Shih YP; Liao YC; Lin Y; Lo SH
    Cancer Res; 2010 Nov; 70(21):8270-5. PubMed ID: 20861185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.
    Zhou X; Zimonjic DB; Park SW; Yang XY; Durkin ME; Popescu NC
    Int J Oncol; 2008 Jun; 32(6):1285-91. PubMed ID: 18497990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
    Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
    Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.
    He D; Mu ZM; Le X; Hsieh JT; Pong RC; Chung LW; Chang KS
    Cancer Res; 1997 May; 57(10):1868-72. PubMed ID: 9157977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence.
    Steiner MS; Zhang Y; Farooq F; Lerner J; Wang Y; Lu Y
    Cancer Gene Ther; 2000 Mar; 7(3):360-72. PubMed ID: 10766342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.
    Li X; Marani M; Yu J; Nan B; Roth JA; Kagawa S; Fang B; Denner L; Marcelli M
    Cancer Res; 2001 Jan; 61(1):186-91. PubMed ID: 11196158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.